CSIG-32. microRNA 211, A POTENTIAL THERAPEUTIC AGENT FOR GROUP 3 MEDULLOBLASTOMA IN CHILDREN
Keisuke Katsushima(Johns Hopkins University), Ranjan J. Perera(Johns Hopkins University), Haritha Kunhiraman(Emory University), Eric H. Raabe(Johns Hopkins University), Bongyong Lee(Johns Hopkins University), Stacie Stapleton(Johns Hopkins University), Charles G. Eberhart(Johns Hopkins University), Menglang Yuan(Johns Hopkins University), George I. Jallo(Johns Hopkins University)
Cited by 2
Related Papers
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Altered Telomeres in Tumors with <i>ATRX</i> and <i>DAXX</i> Mutations
|Science|2011|1.1k
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711